✦ LIBER ✦

O-217 A randomized phase III trial of gemcitabine (G) in combination with carboplatin (C) or paclitaxel (P) versus paclitaxel plus carboplatin in advanced (Stage IIIB, IV) Non-Small Cell Lung Cancer (NSCLC)

✍ Scribed by Treat, Joe; Chandra, Belani P.; Edelman, Martin; Socinski, Mark; Gonin, R.; Ansari, R.; Gillenwater, Heidi; Rogers, J.; Obasaju, Coleman; Comis, R.

Book ID: 118571607
Publisher: Elsevier Science
Year: 2003
Tongue: English
Weight: 170 KB
Volume: 41
Category: Article
ISSN: 0169-5002
DOI: 10.1016/s0169-5002(03)91875-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

O-220 Gemcitabine plus cisplatin versus

O-220 Gemcitabine plus cisplatin versus gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: A phase III randomized trial

✍ Zatloukal, Petr; Petruzelka, Lubos; Zemanova, Milada; Kolek, Vitezslav; Skrickov 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 174 KB

O-082 A randomized phase III trial compa

O-082 A randomized phase III trial comparing ionafarnib/carboplatin/paclitaxel versus carboplatin/paclitaxel (CP) in chemotherapy-naive patients with advanced or metastatic non-small cell lung cancer (NSCLC)

✍ Blumenschein, G.; Ludwig, C.; Thomas, G.; Tan, E.; Fanucchi, M.; Santoro, A.; Cr 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 130 KB

Gemcitabine plus cisplatin vs. gemcitabi

Gemcitabine plus cisplatin vs. gemcitabine plus carboplatin in stage IIIb and IV non-small cell lung cancer: a phase III randomized trial

✍ Zatloukal, Petr; Petruželka, Luboš; Zemanová, Milada; Kolek, Vı́tězslav; Skřičko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 223 KB

O-094 Paclitaxel and gemcitabine vs carb

O-094 Paclitaxel and gemcitabine vs carboplatin and gemcitabine. A multicenter, phase III randomized trial in patients with advanced inoperable Non-small cell lung cancer (NSCLC)

✍ Kosmidis, P.; Kalofonos, C.; Syrigos, K.; Skarlos, D.; Fountzilas, G.; Nicolaide 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 138 KB

A multicenter randomized trial of paclit

A multicenter randomized trial of paclitaxel (175 mg/m2) plus carboplatin (6AUC) versus paclitaxel (225 mg/m2) plus carboplatin (6AUC) in advanced non-small cell lung cancer (NSCLC)

✍ P.A. Kosmidis; N. Mylonakis; D. Skarlos; E. Samantas; M.A. Demopoulos; C. Papadi 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 146 KB

Paclitaxel and carboplatin in combinatio

Paclitaxel and carboplatin in combination with gemcitabine (PCG): A phase I–II trial in advanced non-small cell lung cancer (NSCLC)

✍ Ceresoli, G.L; Favaretto, A; Paccagnella, A; Barbieri, F; Bearz, A; Schiavon, A. 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 121 KB